Psych News Alert | brexanolone

Oral Medication Shows Promise for Postpartum Depression in Phase 3 Trial

Jul 1, 2021 12:00:00 AM

FDA Approves First Medication Specifically for Postpartum Depression

Mar 20, 2019 12:00:00 AM

Yesterday the U.S. Food and Drug Administration (FDA) approved Zulresso (brexanolone) for the treatm...

New Drug Shows Promising Results in Treatment of Postpartum Depression

Jun 16, 2017 12:00:00 AM

In a small sample of women with severe postpartum depression, infusion of the compound brexanolone r...